Virus Filtration Market Size Projected to Reach USD 15 Billion by 2035, Driven by Surging Biologics Demand and 14.3% CAGR – SNS Insider
Growing biologics pipeline, rising cell & gene therapy investments, and strict viral safety mandates from global regulators are driving the virus filtration market through 2035.
Austin, United States, March 24, 2026 (GLOBE NEWSWIRE) — Virus Filtration Market Size & Growth Analysis:
According to SNS Insider, The Virus Filtration Market size was valued at USD 5.71 billion in 2025 and is expected to reach USD 15.00 billion by 2035, growing at a CAGR of 10.15% over the forecast period of 2026-2035. Global virus filtration market expansion is being supported by the biopharmaceutical and biotechnology sectors’ growing demand for complete viral clearing technology due to the necessity for product safety of biologics, vaccines, blood products, and advanced therapeutic medical goods.
Get a Sample Report of Virus Filtration Market: https://www.snsinsider.com/sample-request/6956
The U.S. Virus Filtration Market size was valued at USD 2.28 billion in 2025 and is expected to reach USD 6.15 billion by 2035, growing at a CAGR of 10.42% during 2026 to 2035. Due in large part to the highly developed biopharmaceutical industry, FDA regulations pertaining to viral safety, and substantial investments in the research and development of biologics and cell and gene therapies, the U.S. holds the largest share of the global virus filtration market.
Rising Biologics Production and Viral Safety Regulatory Requirements to Propel Market Expansion Globally
One of the primary factors propelling the viral filtration industry is the expanding worldwide market for monoclonal antibodies, recombinant proteins, vaccines, and items produced from plasma. Strong viral clearance investigations must be carried out before biological products can be approved, according to regulatory agencies, such as the FDA, EMA, and WHO. As a result, there is a steady demand for downstream chromatography products, validation test kits, and virus-retentative filters. The market for virus filtering solutions has also grown as a result of the emergence of biosimilars. Another element that will support the expansion of the virus filtering business is the creation of COVID-19 vaccines utilizing mRNA technology.
Major Virus Filtration Companies Analysis Listed in the Report are
- Merck KGaA
- Sartorius AG
- Cytiva
- Pall Corporation
- Thermo Fisher Scientific
- Asahi Kasei Medical Co., Ltd.
- Charles River Laboratories International
- Lonza Group AG
- Repligen Corporation
- 3M Purification Inc.
- Parker Hannifin Corporation
- Bio-Rad Laboratories, Inc.
- Meissner Filtration Products, Inc.
- WuXi Biologics
- Entegris, Inc.
- Cobetter Filtration Equipment Co., Ltd.
- Novasep Holding SAS
- Agilent Technologies, Inc.
- Eurofins Scientific SE
- Clean Harbors, Inc.
Segmentation Analysis:
By Speed
Consumables held the largest share of approximately 57.42% in 2025 due to the frequent demand of virus retentive membrane filters, kits & reagents and single use filtration assemblies as part of biologics production processes. The services segment is expected to register the highest growth with a CAGR of 11.23% owing to the growing trend of outsourcing of viral clearance validation studies, filter performance qualification, and regulatory support services to contract testing organization (CTOs).
By Technology
The filtration technology segment had the highest share in terms of revenue, 61.85%, in 2025, due to the wide range of applicability in the manufacturing of biologics globally. The chromatography segment is expected to register the highest CAGR, approximately 11.47%, in the range from 2026 to 2035, due to the incorporation of this technology in biologic purification platforms as an orthogonal viral clearance step.
By Application
The biologicals segment accounted for the leading share of nearly 64.32% in 2025 and is expected to register the highest growth with a CAGR of 11.06% during the forecast period. The growth is driven by strong demand in vaccines and therapeutics manufacturing, plasma-derived blood products, and the growing market in cellular and gene therapy.
By End-Use
In 2025, the biopharma industry and biotechnology firms accounted for the biggest market share of about 54.71% driven by large-scale in-house production of biologics and such a requirement to have validated viral clearance in GMP environments. The contract research organizations are projected to have the highest CAGR of about 11.84% during 2023-2035 due to the increasing outsourcing of viral safety testing, clearance study development, and regulatory support to specialized CRO firms globally.
Need Any Customization Research on Virus Filtration Market, Enquire Now: https://www.snsinsider.com/enquiry/6956
Virus Filtration Market Segmentation
By Product
- Consumables
- Kits and Reagents
- Others
- Instruments
- Filtration Systems
- Chromatography Systems
- Services
By Technology
- Filtration
- Consumables
- Instruments
- Services
- Chromatography
- Consumables
- Instruments
- Services
By Application
- Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Stem Cell Products
- Medical Devices
- Water Purification
- Air Purification
By End-Use
- Biopharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Medical Device Companies
- Academic Institutes & Research Laboratories
Regional Insights:
North America dominated the viral filtering market in 2025, accounting for more than 42.21% of the total. However, this is because of its robust biopharma industrial foundation, as well as the FDA’s robust CCV vaping safety testing and the large number of CDMOs and biologic medication developers, including those in the U.S.
The Asia Pacific region holds the highest growth potential for the virus filtration market, growing at a CAGR of 12.35%, owing to the increasing biopharmaceutical manufacturing capacity within the countries of China, India, South Korea, and Japan.
Recent Developments:
- In February 2025, Merck KGaA launched an enhanced Viresolve Pro filtration platform with improved flux performance and a pre-validated, audit-ready viral clearance data package, designed to reduce regulatory submission timelines for biopharmaceutical manufacturers.
- In September 2024, Sartorius AG expanded its BioStat STR bioreactor line with an integrated downstream viral filtration module, enabling seamless end-to-end bioprocessing from cell culture to viral clearance in a single automated platform for monoclonal antibody manufacturers.
Exclusive Sections of the Report (The USPs):
- VIRAL CLEARANCE PERFORMANCE & LRV BENCHMARKING – helps you understand filtration efficiency across filter types, virus categories, and system formats, enabling evaluation of product performance and safety standards.
- REGULATORY COMPLIANCE & VALIDATION METRICS – helps you assess FDA, EMA, and ICH compliance adoption, approval success rates, and challenges in viral safety validation processes.
- BIOPROCESSING ADOPTION & SINGLE-USE TECHNOLOGY TRENDS – helps you evaluate the shift toward single-use filtration systems, CDMO outsourcing, and integration with continuous bioprocessing platforms.
- FILTER PERFORMANCE & OPERATIONAL EFFICIENCY INSIGHTS – helps you analyze fouling rates, flux decline, and scalability from lab to GMP manufacturing, ensuring process reliability.
- PRICING, CAPEX & SUPPLY CHAIN RISK ANALYSIS – helps you understand cost trends, capital investment requirements, and supply chain vulnerabilities for critical filtration components.
- R&D INVESTMENT & TECHNOLOGY INNOVATION LANDSCAPE – helps you track investment allocation and innovation trends among key players driving advancements in virus filtration technologies.
Virus Filtration Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 5.71 Billion |
| Market Size by 2035 | USD 15.00 Billion |
| CAGR | CAGR of 10.15% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Purchase Single User PDF of Virus Filtration Market Report (20% Discount): https://www.snsinsider.com/checkout/6956
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Market Overview
4. Statistical Insights & Trends Reporting
5. Virus Filtration Market Segmental Analysis & Forecast, By Product
6. Virus Filtration Market Segmental Analysis & Forecast, By Technology
7. Virus Filtration Market Segmental Analysis & Forecast, By Application
8. Virus Filtration Market Segmental Analysis & Forecast, By End Use
9. Virus Filtration Market Segmental Analysis & Forecast, By Region
10. Competitive Landscape
11. Analyst Recommendations
12. Assumptions
13. Disclaimer
14. Appendix
Browse More Reports
Single-use Bioprocessing Market
Cell & Gene Therapy Manufacturing Services Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.
